Fig. 1From: Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)Flowchart (FAS, full analysis set; OHA-Q, oral hypoglycemic agent questionnaire)Back to article page